Concepedia

Jungyeon Hwang

JH

Statistics

Publications

35

Citations

3.2K

H-Index

26

Active since

1993

Affiliations

Calando Pharmaceuticals (United States)(Current)

California Institute of Technology

MingDao University

Cerulean Pharma (United States)

National University of Tainan

Jungyeon Hwang is an author at Calando Pharmaceuticals (United States) specializing in pharmacology, nanomedicine, and engineering.

ORCID

Publications per year

1993–2022

35

Publications

35

Role of <scp>l</scp>-3,4-Dihydroxyphenylalanine in Mussel Adhesive Proteins

Miaoer Yu, Jungyeon Hwang, Timothy J. Deming · Journal of the American Chemical Society · 1999 · 631 citations

, , +11

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

Glen J. Weiss, Joseph Chao, Jeffrey D. Neidhart et al. · Investigational New Drugs · 2013 · 220 citations · Full text

, , +14

Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models

Thomas Schluep, Jungyeon Hwang, Jianjun Cheng et al. · Clinical Cancer Research · 2006 · 219 citations · Full text

, , +15

Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat‡§

Jungyeon Hwang, T. L. Yaksh · Regional Anesthesia & Pain Medicine · 1997 · 172 citations

, , +17

Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements

Thomas Schluep, Jungyeon Hwang, Isabel J. Hildebrandt et al. · Proceedings of the National Academy of Sciences · 2009 · 168 citations · Full text

, , +15

1–5 of 35